Changes in Global Initiative for Chronic Obstructive Lung Disease ABCD Groups and the Impact of Regrouping on Treatment: A Comparison of 2017 and 2014.
作者信息
Cui Ya-Nan, Chen Ping, Dai Zhong-Shang, Chen Yan
机构信息
Department of Respiratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
出版信息
Chin Med J (Engl). 2018 May 5;131(9):1113-1114. doi: 10.4103/0366-6999.230737.
Abstract
摘要
相似文献
1
Changes in Global Initiative for Chronic Obstructive Lung Disease ABCD Groups and the Impact of Regrouping on Treatment: A Comparison of 2017 and 2014.慢性阻塞性肺疾病全球倡议ABCD分组的变化及重新分组对治疗的影响：2017年与2014年的比较
Chin Med J (Engl). 2018 May 5;131(9):1113-1114. doi: 10.4103/0366-6999.230737.
2
Global initiative for chronic obstructive lung diseases (GOLD): time to act.慢性阻塞性肺疾病全球倡议（GOLD）：是时候行动了。
Eur Respir J. 2001 Dec;18(6):901-2.
3
Global initiative for chronic obstructive lung disease (GOLD) 2018 report: Highlighting an incorrect information.慢性阻塞性肺疾病全球倡议（GOLD）2018年报告：突出一个错误信息。
Pulm Pharmacol Ther. 2018 Apr;49:10. doi: 10.1016/j.pupt.2017.12.009. Epub 2017 Dec 28.
4
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.慢性阻塞性肺疾病的当前争议。慢性阻塞性肺疾病全球倡议科学委员会的报告。
Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS.
5
Global Initiative on Obstructive Lung Disease revised: what constitutes a guideline?慢性阻塞性肺疾病全球倡议修订版：什么构成了一项指南？
Am J Respir Crit Care Med. 2013 May 15;187(10):1035-6. doi: 10.1164/rccm.201210-1873ED.
6
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update.慢性阻塞性肺疾病全球诊断、管理和预防策略：2003年更新版
Eur Respir J. 2003 Jul;22(1):1-2. doi: 10.1183/09031936.03.00063703.
7
8
Comorbidities and chronic obstructive pulmonary disease: is there a place for lung fibrosis?合并症与慢性阻塞性肺疾病：肺纤维化是否与之相关？
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1367. doi: 10.1164/rccm.201305-0927LE.
9
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.应用 2017 年新版全球慢性阻塞性肺疾病倡议分类标准预测慢性阻塞性肺疾病患者的死亡率：一项队列研究。
Lancet Respir Med. 2018 Mar;6(3):204-212. doi: 10.1016/S2213-2600(18)30002-X. Epub 2018 Jan 10.
10
Reply: Comorbidities and chronic obstructive pulmonary disease: is there a place for lung fibrosis?回复：合并症与慢性阻塞性肺疾病：肺纤维化是否有一席之地？
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1368. doi: 10.1164/rccm.201307-1263LE.
本文引用的文献
1
Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.根据《慢性阻塞性肺疾病全球倡议（GOLD）2017》，定义的变化导致慢性阻塞性肺疾病（COPD）各分类的临床特征发生变化：一项中国全国性横断面调查。
Int J Chron Obstruct Pulmon Dis. 2017 Oct 20;12:3095-3102. doi: 10.2147/COPD.S142801. eCollection 2017.
2
GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort.《慢性阻塞性肺疾病全球倡议2017》迈向基于表型的方法？来自中东欧慢性阻塞性肺疾病表型（POPE）队列的分析
Eur Respir J. 2017 Apr 26;49(4). doi: 10.1183/13993003.02518-2016. Print 2017 Apr.
3
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.COPDGene 研究中的 GOLD 2011 疾病严重程度分类：一项前瞻性队列研究。
Lancet Respir Med. 2013 Mar;1(1):43-50. doi: 10.1016/S2213-2600(12)70044-9. Epub 2012 Sep 3.
Zotero 插件